pantoprazole has been researched along with Acute Edematous Pancreatitis in 10 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to investigate effects of somatostatin combined with pantoprazole on serum C-reactive protein (CRP) and intercellular adhesion molecule-1 (ICAM-1) in severe acute pancreatitis (SAP) patients." | 9.30 | Effects of Somatostatin Combined with Pantoprazole on Serum C-Reactive Protein and Intercellular Adhesion Molecule-1 in Severe Acute Pancreatitis. ( Huang, L; Liu, J; Liu, Y; Wang, G; Wang, J; Xu, X, 2019) |
| " Her postoperative course was complicated by a mucormycosis infection, gastrointestinal bleed, and necrotizing pancreatitis requiring treatment with liposomal amphotericin B and pantoprazole 80 mg twice daily." | 8.12 | Hepatitis C viral clearance with coadministration of crushed sofosbuvir/velpatasvir and high-dose pantoprazole after liver transplantation. ( Bova, SE; Freedman, SR; Pluckrose, DM; Szczepanik, A, 2022) |
| "This case report highlights a very rare adverse drug reaction caused by oral pantoprazole resulting in acute pancreatitis." | 7.78 | Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. ( Das, S; Dey, JK; Ganguly, A; Ghosh, A; Mondal, S; Saha, I, 2012) |
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 5.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| "The objective of this study was to investigate effects of somatostatin combined with pantoprazole on serum C-reactive protein (CRP) and intercellular adhesion molecule-1 (ICAM-1) in severe acute pancreatitis (SAP) patients." | 5.30 | Effects of Somatostatin Combined with Pantoprazole on Serum C-Reactive Protein and Intercellular Adhesion Molecule-1 in Severe Acute Pancreatitis. ( Huang, L; Liu, J; Liu, Y; Wang, G; Wang, J; Xu, X, 2019) |
| "Treatment with pantoprazole did not have influence on the clinical course of acute pancreatitis." | 5.16 | [Effect of proton pump inhibitor in patients with acute pancreatitis - pilot study]. ( Hong, SP; Kim, WH; Ko, KH; Kwon, CI; Park, PW; Yoo, JH; Yoo, KH; Yoon, H, 2012) |
| " Her postoperative course was complicated by a mucormycosis infection, gastrointestinal bleed, and necrotizing pancreatitis requiring treatment with liposomal amphotericin B and pantoprazole 80 mg twice daily." | 4.12 | Hepatitis C viral clearance with coadministration of crushed sofosbuvir/velpatasvir and high-dose pantoprazole after liver transplantation. ( Bova, SE; Freedman, SR; Pluckrose, DM; Szczepanik, A, 2022) |
| "gov and Cochrane Library from inception to June 30,2021 to retrieve relevant studies using the search strategy: ("Proton pump inhibitors" OR "PPI" OR "PPIs" OR "Omeprazole" OR "Tenatoprazole" OR "Pantoprazole" OR "acid suppression therapy" OR "acid suppression drugs") AND ("pancreatitis" OR "pancreatitides")." | 4.02 | Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis. ( Cheng, T; Gu, ZH; Han, TY; Liu, BF; Pan, P; Yu, H, 2021) |
| "This case report highlights a very rare adverse drug reaction caused by oral pantoprazole resulting in acute pancreatitis." | 3.78 | Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. ( Das, S; Dey, JK; Ganguly, A; Ghosh, A; Mondal, S; Saha, I, 2012) |
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 1.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| "Acute pancreatitis is one such rare gastrointestinal manifestation of acute pancreatitis." | 1.35 | Acute abdomen due to acute pancreatitis--a rare presentation of leptospirosis. ( Antony, T; Baburaj, P; Harikrishnan, BL; Louis, F, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pluckrose, DM | 1 |
| Szczepanik, A | 1 |
| Bova, SE | 1 |
| Freedman, SR | 1 |
| Tas, N | 1 |
| Mengen, E | 1 |
| Goncu, S | 1 |
| Tasar, S | 1 |
| Kiremitci, S | 1 |
| Ucakturk, A | 1 |
| Murthy, RN | 1 |
| Viswanathan, S | 1 |
| Jain, D | 1 |
| Cheng, T | 1 |
| Liu, BF | 1 |
| Han, TY | 1 |
| Gu, ZH | 1 |
| Pan, P | 1 |
| Yu, H | 1 |
| Occhipinti, V | 1 |
| Segato, S | 1 |
| Carrara, A | 1 |
| Orlando, S | 1 |
| Conte, D | 1 |
| Liu, J | 1 |
| Wang, G | 1 |
| Liu, Y | 1 |
| Huang, L | 1 |
| Xu, X | 1 |
| Wang, J | 1 |
| Baburaj, P | 1 |
| Antony, T | 1 |
| Louis, F | 1 |
| Harikrishnan, BL | 1 |
| Hackert, T | 1 |
| Tudor, S | 1 |
| Felix, K | 1 |
| Dovshanskiy, D | 1 |
| Hartwig, W | 1 |
| Simon, WA | 1 |
| Werner, J | 1 |
| Das, S | 1 |
| Ganguly, A | 1 |
| Ghosh, A | 1 |
| Mondal, S | 1 |
| Dey, JK | 1 |
| Saha, I | 1 |
| Yoo, JH | 1 |
| Kwon, CI | 1 |
| Yoo, KH | 1 |
| Yoon, H | 1 |
| Kim, WH | 1 |
| Ko, KH | 1 |
| Hong, SP | 1 |
| Park, PW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents (PROTOCOL)[NCT05817721] | 639 participants (Anticipated) | Observational | 2023-05-05 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for pantoprazole and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Effects of Somatostatin Combined with Pantoprazole on Serum C-Reactive Protein and Intercellular Adhesion Molecule-1 in Severe Acute Pancreatitis.
Topics: Adult; C-Reactive Protein; Drug Therapy, Combination; Female; Hormones; Humans; Intercellular Adhesi | 2019 |
[Effect of proton pump inhibitor in patients with acute pancreatitis - pilot study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; | 2012 |
8 other studies available for pantoprazole and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Hepatitis C viral clearance with coadministration of crushed sofosbuvir/velpatasvir and high-dose pantoprazole after liver transplantation.
Topics: Adult; Antiviral Agents; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Trans | 2022 |
Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis.
Topics: Acute Disease; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Humans; Pancreatitis; Pantop | 2023 |
Multiple ecchymotic signs in acute pancreatitis.
Topics: Abdomen; Abdominal Pain; Acute Disease; Adult; Analgesics, Opioid; Drug Therapy, Combination; Ecchym | 2020 |
Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Humans; Meta-Analysis as Topic; Omeprazole; Pancreatitis; P | 2021 |
ERCP or NO ERCP: the case report of a frail patient.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Aged; Angiotensin-Converting Enzyme Inhibit | 2018 |
Acute abdomen due to acute pancreatitis--a rare presentation of leptospirosis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdomen, Acute; Acute Disease; Amylases; Diagnosis, Differe | 2008 |
Effects of pantoprazole in experimental acute pancreatitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cell Movement; Ceruletide; H(+)-K(+)-Exchanging AT | 2010 |
Oral pantoprazole-induced acute pancreatitis in an 11-year-old child.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Child; Gastroesophageal Reflux; Human | 2012 |